Your only treatment of mesothelioma news source!
Click on each item to read full story.

 
Mesothelioma Compensation Center Urges Diagnosed Victims Who Were Exposed To Asbestos At A Nuclear Power Plant To Call ...
read story
WASHINGTON, March 5, 2015 /PRNewswire/ -- The Mesothelioma Compensation Center is 100% focused on providing diagnosed victims of this rare form of cancer with the best possible compensation, especially ...
 
New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma
read story
Polish researchers have just published evidence that shoulder pain can sometimes be one of the first signs of malignant pleural mesothelioma. (PRWeb March 06, 2015) Read the full story at http://www.prweb.com/releases/2015/03/prweb12562517.htm
 
Mesothelioma Compensation Center Shares University of Montana's History of Asbestos With Diagnosed Victims and Urges ...
read story
WASHINGTON, March 3, 2015 /PRNewswire/ -- The Mesothelioma Compensation Center says, "The best weapon any diagnosed victim of a rare cancer can have is knowledge, which is why we wanted to share the University of Montana's history of asbestos exposure. The Mesothelioma Compensation Center says, "We want every diagnosed victim of mesothelioma in the United States to read the University of Montana ...
 
New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma
read story
Mesothelioma lawyers of The Law Office of Melinda J. Helbock A.P.C. say the FDA’s approval of a drug designed to kill cancer stem cells as “orphan drug designation” gives hope to the future of mesothelioma patients. (PRWeb February 27, 2015) Read the full story at http://www.prweb.com/releases/mesothelioma-drug/fda-designation/prweb12549108.htm
 
Research Study Highlights Promising New Mesothelioma Therapies, According to Surviving Mesothelioma
read story
One of the country’s top mesothelioma researchers has published a new summary of some of the most promising emerging therapies for the deadly cancer. (PRWeb February 25, 2015) Read the full story at http://www.prweb.com/releases/2015/02/prweb12536377.htm
 
Mesothelioma Compensation Center Urges US Navy Veterans With Mesothelioma to Call for a Customized List of Tips on How ...
read story
WASHINGTON, Feb. 26, 2015 /PRNewswire/ -- The Mesothelioma Compensation Center is now offering US Navy Veterans who have been diagnosed with mesothelioma and/or their family member a list of helpful tips related to compensation, if Medicare allows them to seek treatment from a major national-caliber hospital. The Mesothelioma Compensation Center is now urging US Navy Veterans who have been ...
 
New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma
read story
Italian researchers say a mesothelioma patient’s response to a treatment for excess lung fluid can also help determine prognosis. (PRWeb March 02, 2015) Read the full story at http://www.prweb.com/releases/2015/03/prweb12552241.htm
 
Mesothelioma Victims Center Offers Valuable Information and Guidance for Power Plant Workers Diagnosed with ...
read story
WASHINGTON, Feb. 27, 2015 /PRNewswire/ -- The Mesothelioma Victims Center is now making the best possible compensation a reality for former power plant workers who have been diagnosed with mesothelioma, because these types of individuals could qualify for multi-million dollar mesothelioma settlements. The Mesothelioma Victims Center is making the best possible compensation for former power plant ...
 
Verastem Receives Orphan Drug Designation from FDA for VS-5584 in Mesothelioma
read story
Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that VS-5584 has received orphan drug designation from the U.S.
 
Novartis, Verastem & Cepheid Making Biotech Headlines On Friday
read story
Novartis AG (ADR) (NYSE: NVS ) obtained approval for an accelerated review of an experimental heart-failure treatment Friday, while Pfizer Inc. (NYSE: PFE )'s new formulation of oxycondone aimed at foiling ...